company background image
ASXC

Asensus Surgical NYSEAM:ASXC Stock Report

Last Price

US$0.42

Market Cap

US$99.0m

7D

-2.7%

1Y

-70.8%

Updated

25 Nov, 2022

Data

Company Financials +
ASXC fundamental analysis
Snowflake Score
Valuation0/6
Future Growth2/6
Past Performance0/6
Financial Health6/6
Dividends0/6

ASXC Stock Overview

Asensus Surgical, Inc., a medical device company, engages in the research, development, and sale of medical device robotics to enhance minimally invasive surgery (MIS) in the United States, Europe, and Asia.

Asensus Surgical, Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Asensus Surgical
Historical stock prices
Current Share PriceUS$0.42
52 Week HighUS$1.51
52 Week LowUS$0.35
Beta1.31
1 Month Change-10.08%
3 Month Change-27.90%
1 Year Change-70.76%
3 Year Change-84.00%
5 Year Change-98.63%
Change since IPO-98.00%

Recent News & Updates

Recent updates

Shareholder Returns

ASXCUS Medical EquipmentUS Market
7D-2.7%1.9%1.3%
1Y-70.8%-20.2%-18.5%

Return vs Industry: ASXC underperformed the US Medical Equipment industry which returned -20.2% over the past year.

Return vs Market: ASXC underperformed the US Market which returned -18.5% over the past year.

Price Volatility

Is ASXC's price volatile compared to industry and market?
ASXC volatility
ASXC Average Weekly Movement8.8%
Medical Equipment Industry Average Movement8.7%
Market Average Movement7.4%
10% most volatile stocks in US Market15.5%
10% least volatile stocks in US Market3.3%

Stable Share Price: ASXC is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 9% a week.

Volatility Over Time: ASXC's weekly volatility (9%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
2006160Anthony Fernandohttps://www.asensus.com

Asensus Surgical, Inc., a medical device company, engages in the research, development, and sale of medical device robotics to enhance minimally invasive surgery (MIS) in the United States, Europe, and Asia. It digitizes the interface between the surgeon and the patient to pioneer a new era of Performance-Guided surgery by unlocking clinical intelligence for surgeons to enable consistently superior outcomes and a new standard of surgery. The company’s products include Senhance Surgical system, a multi-port robotic surgery system that allows up to four arms to control robotic instruments and a camera for laparoscopic procedures.

Asensus Surgical, Inc. Fundamentals Summary

How do Asensus Surgical's earnings and revenue compare to its market cap?
ASXC fundamental statistics
Market CapUS$99.05m
Earnings (TTM)-US$73.55m
Revenue (TTM)US$7.10m

14.0x

P/S Ratio

-1.3x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
ASXC income statement (TTM)
RevenueUS$7.10m
Cost of RevenueUS$10.86m
Gross Profit-US$3.76m
Other ExpensesUS$69.79m
Earnings-US$73.55m

Last Reported Earnings

Sep 30, 2022

Next Earnings Date

n/a

Earnings per share (EPS)-0.31
Gross Margin-52.99%
Net Profit Margin-1,036.09%
Debt/Equity Ratio0%

How did ASXC perform over the long term?

See historical performance and comparison